Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 220

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 220
---
2     
 of the Corporations Act;                                                                    |

| ● | does not                                                                                     
 constitute or involve a recommendation to acquire, an offer or invitation for issue or sale, 
 an offer or invitation to arrange the issue or sale, or an issue or sale, of interests to    
 a “retail client” (as defined in section 761G of the Corporations Act and                    
 applicable regulations) in Australia; and                                                    |

| ● | may only                                                                                       
 be provided in Australia to select investors who are able to demonstrate that they fall within 
 one or more of the categories of investors, or Exempt Investors, available under section 708   
 of the Corporations Act.                                                                       |

The
Class A Ordinary Shares may not be directly or indirectly offered for subscription or purchased
or sold, and no invitations to subscribe for or buy the Class A Ordinary Shares may be issued,
and no draft or definitive offering memorandum, advertisement or other offering material
relating to any Class A Ordinary Shares may be distributed in Australia, except where disclosure
to investors is not required under Chapter 6D of the Corporations Act or is otherwise
in compliance with all applicable Australian laws and regulations. By submitting an application
for the Class A Ordinary Shares, you represent and warrant to us that you are an Exempt Investor.

As any offer of Class A Ordinary Shares under
this prospectus will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities
for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under
Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the Class A Ordinary Shares you
undertake to us that you will not, for a period of 12 months from the date of issue of the Class A Ordinary Shares, offer, transfer,
assign or otherwise alienate those securities to investors in Australia except in circumstances where disclosure to investors is not
required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC.

<div align='center'>126</div>

Notice to Prospective Investors in Canada

Resale restrictions.The distribution of the Class A Ordinary Shares in Canada is being made
only in the provinces of Ontario, Quebec, Alberta and British Columbia on a private placement
basis exempt from the requirement that we prepare and file a prospectus with the securities
regulatory authorities in each